Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease

Clinical Neurophysiology

Volumn 120, Issue 10, 2009, Pages 1852-1858

  Lukhanina, E P ^a   Kapustina, M T ^b   Berezetskaya, N M ^b   Karaban, I N ^b  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b INSTITUTE OF GERONTOLOGY   (Ukraine)

Author keywords

Auditory evoked potentials; Levodopa; Paired click stimulation; Parkinson's disease; Postexcitatory inhibition; Potential P300

Indexed keywords

AMANTADINE; CARBIDOPA; LEVODOPA; PRAMIPEXOLE; SELEGILINE;

ADULT; AGED; ARTICLE; AUDITORY CORTEX; AUDITORY STIMULATION; COGNITION; CONTROLLED STUDY; DRUG MECHANISM; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ACOUSTIC STIMULATION; AGED; ANTIPARKINSON AGENTS; AUDITORY CORTEX; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEURAL INHIBITION; PARKINSON DISEASE;

EID: 70350008264     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2009.07.040     Document Type: Article

References (74)

1. Abbruzzese G., and Berardelli A. Sensorimotor integration in movement disorders. Mov Disord 18 (2003) 231-240
2. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., and Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17 (1982) 639-654
3. Alexander G.E., and Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13 (1990) 266-271
4. Angel A. Cortical responses to paired stimuli applied peripherally and at sites along the somato-sensory pathway. J Physiol 191 (1967) 427-448
5. Angel R.W., Quick W.M., Boylls C.C., Weinrich M., and Rodnitzky R.L. Decrement of somatosensory evoked potentials during repetitive stimulation. Electroencephalogr Clin Neurophysiol 60 (1985) 335-342
6. Bares M., Kanovsky P., Klajblova H., and Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur J Neurol 10 (2003) 385-389
7. Bares M., Kanovsky P., and Rektor I. Disturbed intracortical excitability in early Parkinson's disease is L-DOPA dose related: a prospective 12-month paired TMS study. Parkinsonism Relat Disord 13 (2007) 489-494
8. Berardelli A., Rona S., Inghilleri M., and Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain 119 (1996) 71-77
9. Bergson C., Mrzljak L., Smiley J.F., Pappy M., Levenson R., and Goldman-Rakic P.S. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15 (1995) 7821-7836
10. Boecker H., Ceballos-Baumann A., Bartenstein P., Weindl A., Siebner H.R., Fassbender T., et al. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2) (15) O-PET. Brain 122 Pt 9 (1999) 1651-1665
11. Cantello R., Tarletti R., and Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 38 (2002) 309-327
12. Chen K.J., Lin R.T., Liu C.K., Tai C.T., and Lai C.L. Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's disease. Parkinsonism Relat Disord 12 (2006) 453-458
13. Chu Z., and Hablitz J.J. GABA (B) receptor-mediated heterosynaptic depression of excitatory synaptic transmission in rat frontal neocortex. Brain Res 959 (2003) 39-49
14. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madison A., Nagamoto H.T., et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res 10 (1993) 131-141
15. Davis H., Mast T., Yoshie N., and Zerlin S. The slow response of the human cortex to auditory stimuli: recovery process. Electroencephalogr Clin Neurophysiol 21 (1966) 105-113
16. Dawson M.E., Schell A.M., Swerdlow N.R., and Filion D.L. Cognitive, clinical and neurophysiological implications of startle modification. In: Lang P.J., Simons R.F., and Balaban M.T. (Eds). Attention and orienting: sensory and motivational processes (1997), Lawrence Erlbaum, Hillsdale, NJ 257-279
17. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13 (1990) 281-285
18. Deisz R.A. GABA (B) receptor-mediated effects in human and rat neocortical neurones in vitro. Neuropharmacology 38 (1999) 1755-1766
19. Elden A., and Flaten M.A. The relationship of automatic and controlled processing to prepulse inhibition. J Psychophysiol 16 (2002) 46-55
20. Fabiani M., Low K.A., Wee E., Sable J.J., and Gratton G. Reduced suppression or labile memory? Mechanisms of inefficient filtering of irrelevant information in older adults. J Cognitive Neurosci 18 (2006) 637-650
21. Fahn S, Elton R and members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. vol. 2. Florham Park: NJ Macmillan Health Care Information, 1987. p. 153-163, 293-304.
22. Freedman R., Olincy A., Ross R.G., Waldo M.C., Stevens K.E., Adler L.E., et al. The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep 5 (2003) 155-161
23. Gaspar P., Duyckaerts C., Alvarez C., Javoy-Agid F., and Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 30 (1991) 365-374
24. Gonzalez-Islas C., and Hablitz J.J. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. J Neurophysiol 86 (2001) 2911-2918
25. Hanajima R., and Ugawa Y. Intracortical inhibition of the motor cortex in movement disorders. Brain Dev 22 Suppl. 1 (2000) 132-135
26. Hejl A.M., Glenthoj B., Mackeprang T., Hemmingsen R., and Waldemar G. Prepulse inhibition in patients with Alzheimer's disease. Neurobiol Aging 25 (2004) 1045-1050
27. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
28. Holloway R.G., Shoulson I., Fahn S., Kieburtz K., Lang A., Marek K., et al. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson's disease: a 4-year randomized controlled trial. Arch Neurol 61 (2004) 1044-1053
29. Hughes A.I., Ben-Shlomo Y., Daniel S.E., and Lees A.I. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinico-pathologic study. Neurology 42 (1992) 1142-1146
30. Jones C.K., and Shannon H.E. Lesions of the laterodorsal tegmental nucleus disrupt prepulse inhibition of the acoustic startle reflex. Pharmacol Biochem Behav 78 (2004) 229-237
31. Juckel G., Clotz F., Frodl T., Kawohl W., Hampel H., Pogarell O., et al. Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease?. J Clin Neurophysiol 25 (2008) 147-152
32. Kaji R. Basal ganglia as a sensory gating devise for motor control. J Med Invest 48 (2001) 142-146
33. Kaji R., Urushihara R., Murase N., Shimazu H., and Goto S. Abnormal sensory gating in basal ganglia disorders. J Neurol. 252 Suppl. 4 (2005) p. 1V/13-1V/16
34. Kanda F., Jinnai K., Takahashi K., Abe H., Yasuda M., Tada K., et al. Somatosensory evoked potentials in Huntington's disease - studies with paired stimulation. Electromyogr Clin Neurophysiol 29 (1989) 287-291
35. Kawaguchi Y., and Shindou T. Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex. J Neurosci 18 (1998) 6963-6976
36. Kleine B.U., Praamstra P., Stegeman D.F., and Zwarts M.J. Impaired motor cortical inhibition in Parkinson's disease: motor unit responses to transcranial magnetic stimulation. Exp Brain Res 138 (2001) 477-483
37. Klostermann F., Gobbele R., Buchner H., and Curio G. Dissociation of human thalamic and cortical SEP gating as revealed by intrathalamic recordings under muscle relaxation. Brain Res 958 (2002) 146-151
38. Koch M., Kungel M., and Herbert H. Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat. Exp Brain Res 97 (1993) 71-82
39. Krnjevic K., Randic M., and Straughan D.W. Nature of a cortical inhibitory process. J Physiol 184 (1966) 49-77
40. Kugler C.F. The impact of age-related changes in event -related P300 potentials on detecting early cognitive dysfunction. Arch Gerontol Geriatr 25 (1997) 13-26
41. Lagopoulos J., Gordon E., Lim C.L., Bahramali H., Morris J.G., Clouston P., et al. Automatic processing dysfunction in Parkinson's disease. Neurol Res 19 (1997) 609-612
42. Levy G., Tang M.-.X., Cote L.J., Louis E.D., Alfaro B., Mejia H., et al. Motor impairment in PD: Relationship to incident dementia and age. Neurology 55 (2000) 539-544
43. Lewis G.N., and Byblow W.D. Altered sensorimotor integration in Parkinson's disease. Brain 125 (2002) 2089-2099
44. Liberson W.T. Contributions to the history of the discovery of P300. Electromyogr Clin Neurophysiol 34 (1994) 53-57
45. Lukhanina E.P., Burchinskaya L.F., and Kolomiets B.P. Functional and structural modifications in cells of the VA-VL thalamic nuclei under the influence of the neurotoxin MPTP. Neurophysiology 31 (1999) 245-252
46. Marie R.M., Barre L., Rioux P., Allain P., Lechevalier B., and Baron J.C. PET imaging of neocortical monoaminergic terminals in Parkinson's disease. J Neural Transm Park Dis Dement Sect 9 (1995) 55-71
47. Masur H., Althoff S., Erim Y., Oberwittler C., and Hornung W.P. Postexcitatory inhibition after transcranial magnetic stimulation of the motor cortex in patients with drug-induced parkinsonism and in healthy individuals. Int Clin Psychopharmacol 13 (1998) 79-82
48. Mohamed A.S., Iacono R.P., and Yamada S. Normalization of middle latency auditory P1 potential following posterior ansa-pallidotomy in idiopathic Parkinson's disease. Neurol Res 18 (1996) 516-520
49. Moroni F., Tanganelli S., Antonelli T., Carla V., Bianchi C., and Beani L. Modulation of cortical acetylcholine and gamma-aminobutyric acid release in freely moving guinea pigs: effects of clonidine and other adrenergic drugs. J Pharmacol Exp Ther 227 (1983) 435-440
50. Moxon K.A., Gerhardt G.A., and Adler L.E. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia. Biol Cybern 88 (2003) 265-275
51. Nagamoto H.T., Adler L.E., Waldo M.C., Griffith J., and Freedman R. Gating of auditory response is schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schizophr Res 4 (1991) 31-40
52. Nakashima K., Nitta T., and Takahashi K. Recovery function of somatosensory evoked potentials in parkinsonian patients. J Neurol Sci 108 (1992) 24-31
53. Olpe H.R., Steinmann M.W., Greiner K., and Pozza M.F. Contribution of presynaptic GABA-B receptors to paired-pulse depression of GABA-responses in the hippocampus. Naunyn Schmiedebergs Arch Pharmacol 349 (1994) 473-477
54. Pekkonen E., Jousmaki V., Reinikainen K., and Partanen J. Automatic auditory discrimination is impaired in Parkinson's disease. Electroencephalogr Clin Neurophysiol 95 (1995) 47-52
55. Perriol M.P., Dujardin K., Derambure P., Marcq A., Bourriez J.L., Laureau E., et al. Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 76 (2005) 106-108
56. Picton T.W. The P300 wave of the human event-related potential. J Clin Neurophysiol 9 (1992) 456-479
57. Pierantozzi M., Palmieri M.G., Marciani M.G., Bernardi G., Giacomini P., and Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Exp Brain Res 141 (2001) 52-62
58. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 118 (2007) 2128-2148
59. Rektor I., Kaiiovsky P., Bares M., Brazdil M., Streitova H., Klajblova H., et al. A SEEG study of ERP in motor and premotor cortices and in the basal ganglia. Clin Neurophysiol 114 (2003) 463-471
60. Ridding M.C., Inzelberg R., and Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 37 (1995) 181-188
61. Rossini P.M., Filippi M.M., and Vernieri F. Neurophysiology of sensorimotor integration in Parkinson's disease. Clin Neurosci 5 (1998) 121-130
62. Sadekov R.A. Evoked potentials in parkinsonism. Zh Nevropatol Psikhiatr Im S S Korsakova 97 (1997) 64-65
63. Sailer A., Molnar G.F., Paradiso G., Gunraj C.A., Lang A.E., and Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain 126 (2003) 1883-1894
64. Schafer E.W., and Peeke H.V.S. Down syndrome individuals fail to habituate cortical evoked potentials. Am J Ment Defic 87 (1982) 332-337
65. Schneider J.S. Interactions between the basal ganglia, the pontine parabrachial region, and the trigeminal system in cat. Neuroscience 19 (1986) 411-425
66. Shammah-Lagnado S.J., Alheid G.F., and Heimer L. Efferent connections of the caudal part of the globus pallidus in the rat. J Comp Neurol 376 (1996) 489-507
67. Shin R.M., Kato K., and Mikoshiba K. Polysynaptic excitatory pathways induce heterosynaptic depression in the rat auditory cortex. Neurosci Res 40 (2001) 67-74
68. Stanzione P., Fattapposta F., Giunti P., D'Alessio C., Tagliati M., Affricano C., et al. P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalogr Clin Neurophysiol 80 (1991) 446-453
69. Surmeier D.J., and Kitai S.T. State - dependent regulation of neuronal excitability by dopamine. Nihon Shinkei Seishin Yakurigaku Zasshi 17 (1997) 105-110
70. Swick D., Pineda J.A., Schacher S., and Foote S.L. Locus coeruleus neuronal activity in awake monkeys: relationship to auditory P300-like potentials and spontaneous EEG. Exp Brain Res 101 (1994) 86-92
71. Teo Ch., Rasco L., Al-Mefty K., Skinner R.D., Boop F.A., and Garcia-Rill E. Decreased habituation of midlatency auditory evoked responses in Parkinson's disease. Mov Disord 12 (1997) 655-664
72. Ugawa Y., Genba K., Shimpo T., and Mannen T. Somatosensory evoked potential recovery (SEP-R) in myoclonic patients. Electroencephalogr Clin Neurophysiol 80 (1991) 21-25
73. Vieregge P., Verleger R., Wascher E., Stuven F., and Kompf D. Auditory selective attention is impaired in Parkinson's disease-event-related evidence from EEG potentials. Brain Res Cogn Brain Res 2 (1994) 117-129
74. Zhang J., Forkstam C., Engel J.A., and Svensson L. Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology (Berl) 149 (2000) 181-188